TNFRSF1B and neoplasm: In vivo BLI (Figure 1A and B) and ex vivo BLI one month after tumor inoculation (Figure 1C and D) also revealed significantly higher tumor burden in mice deficient for TNFR1 (or TNFR1 and TNFR2) than in wild type mice.